Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.
Batty JA, Hall AS, White HL, Wikstrand J, de Boer RA, van Veldhuisen DJ, van der Harst P, Waagstein F, Hjalmarson Å, Kjekshus J, Balmforth AJ; MERIT-HF Study Group. Batty JA, et al. Among authors: kjekshus j. Clin Pharmacol Ther. 2014 Mar;95(3):321-30. doi: 10.1038/clpt.2013.193. Epub 2013 Sep 30. Clin Pharmacol Ther. 2014. PMID: 24193112 Clinical Trial.
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
Wikstrand J, Hjalmarson A, Waagstein F, Fagerberg B, Goldstein S, Kjekshus J, Wedel H; MERIT-HF Study Group. Wikstrand J, et al. Among authors: kjekshus j. J Am Coll Cardiol. 2002 Aug 7;40(3):491-8. doi: 10.1016/s0735-1097(02)01970-8. J Am Coll Cardiol. 2002. PMID: 12142116 Free article. Clinical Trial.
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. Hjalmarson A, et al. Among authors: kjekshus j. JAMA. 2000 Mar 8;283(10):1295-302. doi: 10.1001/jama.283.10.1295. JAMA. 2000. PMID: 10714728 Clinical Trial.
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. Wikstrand J, et al. Among authors: kjekshus j. Card Electrophysiol Rev. 2003 Sep;7(3):264-75. doi: 10.1023/B:CEPR.0000012438.04416.00. Card Electrophysiol Rev. 2003. PMID: 14739726
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J; MERIT-HF Study Group. Gullestad L, et al. Among authors: kjekshus j. J Am Coll Cardiol. 2005 Jan 18;45(2):252-9. doi: 10.1016/j.jacc.2004.10.032. J Am Coll Cardiol. 2005. PMID: 15653024 Free article. Clinical Trial.
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
Kjekshus J, Dunselman P, Blideskog M, Eskilson C, Hjalmarson A, McMurray JV, Waagstein F, Wedel H, Wessman P, Wikstrand J; CORONA Study Group. Kjekshus J, et al. Eur J Heart Fail. 2005 Oct;7(6):1059-69. doi: 10.1016/j.ejheart.2005.09.005. Eur J Heart Fail. 2005. PMID: 16227145 Free article. Clinical Trial.
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.
van Veldhuisen DJ, Aass H, El Allaf D, Dunselman PH, Gullestad L, Halinen M, Kjekshus J, Ohlsson L, Wedel H, Wikstrand J; MERIT-HF Study Group. van Veldhuisen DJ, et al. Among authors: kjekshus j. Eur J Heart Fail. 2006 Aug;8(5):539-46. doi: 10.1016/j.ejheart.2006.01.015. Epub 2006 Mar 29. Eur J Heart Fail. 2006. PMID: 16567126 Free article. Clinical Trial.
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H; MERIT-HF Study Group. Ghali JK, et al. Among authors: kjekshus j. J Card Fail. 2009 May;15(4):310-8. doi: 10.1016/j.cardfail.2008.11.003. Epub 2008 Dec 23. J Card Fail. 2009. PMID: 19398079 Clinical Trial.
The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA).
Haver VG, Verweij N, Kjekshus J, Fox JC, Wedel H, Wikstrand J, van Gilst WH, de Boer RA, van Veldhuisen DJ, van der Harst P. Haver VG, et al. Among authors: kjekshus j. BMC Med Genet. 2014 Dec 21;15:140. doi: 10.1186/s12881-014-0140-3. BMC Med Genet. 2014. PMID: 25528061 Free PMC article.
Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
Haver VG, Mateo Leach I, Kjekshus J, Fox JC, Wedel H, Wikstrand J, de Boer RA, van Gilst WH, McMurray JJ, van Veldhuisen DJ, van der Harst P. Haver VG, et al. Among authors: kjekshus j. Eur J Heart Fail. 2015 Mar;17(3):313-9. doi: 10.1002/ejhf.237. Epub 2015 Feb 2. Eur J Heart Fail. 2015. PMID: 25639660 Free article. Clinical Trial.
361 results